Literature DB >> 14500712

PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation.

Gress Kadaré1, Madeleine Toutant, Etienne Formstecher, Jean-Christophe Corvol, Michèle Carnaud, Marie-Claude Boutterin, Jean-Antoine Girault.   

Abstract

Focal adhesion kinase (FAK) is a protein tyrosine kinase enriched in focal adhesions, which plays a critical role in integrin-dependent cell motility and survival. The crucial step in its activation is autophosphorylation on Tyr-397, which promotes the recruitment of several enzymes including Src family kinases and the activation of multiple signaling pathways. We found in a yeast two-hybrid screen that the N-terminal domain of FAK interacted with protein inhibitor of activated STAT1 (PIAS1). This interaction was confirmed and shown to be direct using in vitro assays. PIAS1 was co-immunoprecipitated with FAK from transfected cells and brain extracts. PIAS1 has recently been recognized as a small ubiquitin-like modifier (SUMO) ligase. In the presence of PIAS1 and SUMO-1, FAK was sumoylated in intact cells, whereas PYK2, a closely related enzyme, was not. Sumoylation occurred on Lys-152, a residue conserved in FAK during evolution. Sumoylated FAK, like PIAS1, was recovered predominantly from the nuclear fraction. Sumoylation did not require the catalytic activity or autophosphorylation of FAK. In contrast, sumoylation increased dramatically the ability of FAK to autophosphorylate in intact cells and in immune precipitate kinase assays. Endogenous FAK was sumoylated in the presence of PIAS1 and SUMO-1 independently of cell adhesion, and autophosphorylation of sumoylated FAK was persistently increased in suspended cells. These observations show that sumoylation controls the activity of a protein kinase and suggest that FAK may play a novel role in signaling between the plasma membrane and the nucleus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500712     DOI: 10.1074/jbc.M308562200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Conformational dynamics of the focal adhesion targeting domain control specific functions of focal adhesion kinase in cells.

Authors:  Gress Kadaré; Nicolas Gervasi; Karen Brami-Cherrier; Heike Blockus; Said El Messari; Stefan T Arold; Jean-Antoine Girault
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

2.  Mapping residues of SUMO precursors essential in differential maturation by SUMO-specific protease, SENP1.

Authors:  Zheng Xu; Shannon W N Au
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

3.  Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO-specific protease.

Authors:  Zheng Xu; So Fun Chau; Kwok Ho Lam; Ho Yin Chan; Tzi Bun Ng; Shannon W N Au
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

4.  Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation.

Authors:  Ssang-Taek Lim; Xiao Lei Chen; Yangmi Lim; Dan A Hanson; Thanh-Trang Vo; Kyle Howerton; Nicholas Larocque; Susan J Fisher; David D Schlaepfer; Dusko Ilic
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

5.  SUMOylation-regulated protein phosphorylation, evidence from quantitative phosphoproteomics analyses.

Authors:  Qi Yao; Hui Li; Bing-Qian Liu; Xin-Yun Huang; Lin Guo
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

Review 6.  Emerging roles of SUMO modification in arthritis.

Authors:  Dongyao Yan; Francesca J Davis; Andrew D Sharrocks; Hee-Jeong Im
Journal:  Gene       Date:  2010-07-11       Impact factor: 3.688

7.  DeSUMOylating isopeptidase: a second class of SUMO protease.

Authors:  Eun Ju Shin; Hyun Mi Shin; Eori Nam; Won Seog Kim; Ji-Hoon Kim; Byung-Ha Oh; Yungdae Yun
Journal:  EMBO Rep       Date:  2012-04       Impact factor: 8.807

8.  Modification of Akt by SUMO conjugation regulates alternative splicing and cell cycle.

Authors:  Guillermo Risso; Federico Pelisch; Berta Pozzi; Pablo Mammi; Matías Blaustein; Alejandro Colman-Lerner; Anabella Srebrow
Journal:  Cell Cycle       Date:  2013-08-27       Impact factor: 4.534

Review 9.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

10.  Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells.

Authors:  Stuart J Netherton; Shirin Bonni
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.